Source:http://linkedlifedata.com/resource/pubmed/id/16405503
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2006-1-30
|
pubmed:abstractText |
Abstract Studies were performed to determine if cyclooxygenase (COX)-2 regulates muscarinic receptor-initiated signaling involving brain phospholipase A2 (PLA2) activation and arachidonic acid (AA; 20 : 4n-6) release. AA incorporation coefficients, k* (brain [1-14C]AA radioactivity/integrated plasma radioactivity), representing this signaling, were measured following the intravenous injection of [1-14C]AA using quantitative autoradiography, in each of 81 brain regions in unanesthetized COX-2 knockout (COX-2(-/-)) and wild-type (COX-2(+/+)) mice. Mice were administered arecoline (30 mg/kg i.p.), a non-specific muscarinic receptor agonist, or saline i.p. (baseline control). At baseline, COX-2(-/-) compared with COX-2(+/+) mice had widespread and significant elevations of k*. Arecoline increased k* significantly in COX-2(+/+) mice compared with saline controls in 72 of 81 brain regions, but had no significant effect on k* in any region in COX-2(-/-) mice. These findings, when related to net incorporation rates of AA from brain into plasma, demonstrate enhanced baseline brain metabolic loss of AA in COX-2(-/-) compared with COX-2(+/+) mice, and an absence of a normal k* response to muscarinic receptor activation. This response likely reflects selective COX-2-mediated conversion of PLA2-released AA to prostanoids.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Arachidonic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Arecoline,
http://linkedlifedata.com/resource/pubmed/chemical/Cholinergic Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2,
http://linkedlifedata.com/resource/pubmed/chemical/Phospholipases A,
http://linkedlifedata.com/resource/pubmed/chemical/Phospholipases A2
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0022-3042
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
96
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
669-79
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16405503-Animals,
pubmed-meshheading:16405503-Arachidonic Acid,
pubmed-meshheading:16405503-Arecoline,
pubmed-meshheading:16405503-Autoradiography,
pubmed-meshheading:16405503-Body Weight,
pubmed-meshheading:16405503-Brain,
pubmed-meshheading:16405503-Brain Mapping,
pubmed-meshheading:16405503-Cholinergic Agonists,
pubmed-meshheading:16405503-Cyclooxygenase 2,
pubmed-meshheading:16405503-G0 Phase,
pubmed-meshheading:16405503-Male,
pubmed-meshheading:16405503-Mice,
pubmed-meshheading:16405503-Mice, Inbred C57BL,
pubmed-meshheading:16405503-Mice, Knockout,
pubmed-meshheading:16405503-Phospholipases A,
pubmed-meshheading:16405503-Phospholipases A2
|
pubmed:year |
2006
|
pubmed:articleTitle |
Resting and arecoline-stimulated brain metabolism and signaling involving arachidonic acid are altered in the cyclooxygenase-2 knockout mouse.
|
pubmed:affiliation |
Brain Physiology and Metabolism Section, National Institute on Aging, National Institutes of Health, Bethesda,MD 20892-0947, USA. mirvasln@mail.nih.gov
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, N.I.H., Intramural
|